ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Dizal Pharmaceuticals clinical trials

The registry lists 41 studies whose lead sponsor is Dizal Pharmaceuticals. 16 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Keep track of what changes. Save the Dizal Pharmaceuticals studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
20
Recruiting
14
Active, not recruiting
3
Not yet recruiting
2
Terminated
1
Withdrawn
1

Phase

Phase 1
27
Phase 2
20
Phase 3
5

Where

China
28
United States
16
Australia
6
Korea, Republic of
3
Argentina
2
France
2

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Dizal Pharmaceuticals.

  • Dizal Pharmaceuticals
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    39 studies
  • Dizal (Jiangsu) Pharmaceutical Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies

Focus areas

Conditions Dizal Pharmaceuticals leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Carcinoma, Non-Small-Cell Lung12

Studies

Recruiting first, then most recently updated. Showing 41 of 41.